Are you Dr. Lee?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1560 N 115th St
G 16
Seattle, WA 98133Phone+1 206-365-8252Fax+1 206-365-6136
Summary
- Dr. Douglas Lee, MD is an oncologist in Seattle, Washington. He is currently licensed to practice medicine in Washington and Pennsylvania. He is affiliated with UW Medicine/Northwest Hospital & Medical Center, Providence Swedish Edmonds, and Swedish First Hill Campus.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1985 - 1986
UPMC Medical EducationResidency, Internal Medicine, 1983 - 1984- UPMC Medical EducationInternship, Internal Medicine, 1981 - 1982
Yale School of MedicineClass of 1981
Certifications & Licensure
WA State Medical License 1985 - 2026
PA State Medical License 1983 - 1986- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 68 citationsPatient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trialKaren L. Syrjala, Janet R. Abrams, Nayak L. Polissar, Jennifer Hansberry, Jeanne Robison
Pain. 2008-03-01 - 138 citationsSubcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effectsJohn A. Thompson, Douglas J. Lee, Pamela Kidd, E Rubin, Jenny Kaufmann
Journal of Clinical Oncology. 1989-05-01 - 59 citationsInfluence of Schedule of Interleukin 2 Administration on Therapy with Interleukin 2 and Lymphokine Activated Killer CellsJohn A. Thompson, Douglas J. Lee, Catherine G. Lindgren, Lynn A. Benz, Carolyn Collins
Cancer Research. 1989-01-01
Press Mentions
Women Treated with Herceptin Need Heart Monitoring No Matter Their AgeApril 29th, 2016
Professional Memberships
- Member
